Document is current
Any future updates will be listed below
-
Authors
Woodward, Sue https://orcid.org/0000-0001-5390-7253
Graham, Tanya
Beckley-Hoelscher, Nicholas
Beeckman, Dimitri
Chatterton, Christopher
Fader, Mandy
Fitzpatrick, Joanne M.
Harris, Ruth
Kottner, Jan
Norton, Christine
Sooriah, Sangeeta
Worsley, Peter R.
-
Funding
Funding for this research was provided by:
Health Technology Assessment Programme (NIHR128865)
- License Information
-
More Information
Article History
Received: 25 February 2025
Accepted: 17 October 2025
First Online: 26 November 2025
Declarations
:
: All participants gave written informed consent to both participate and for their data to be used in publications. Ethical approval for phase one of the study was obtained from the King’s College London PNM Research Ethics Subcommittee (KCL Ethics Ref: HR-19/20-17478) and for phase three from the Queen Square Research Ethics Committee (REC Reference: 23/LO/0363).
: CN declares the following conflicts of interest: speaker fees from Janssen, WebMD, Medscape, Merck Pharmaceutical, Tillotts Pharma UK and Lilly, and Pfizer advisory board. CC declares the following conflicts: Attends UK Ltd—presentation funding, Clinisupplies UK Ltd—presentation/conference funding, Essity—presentation funding. DB declares the following conflicts: MOLNLYCKE HEALTH CARE US, LLC (independent contractor—consultant); Urgo Medical North America, LLC (independent contractor—consultant); 3M Company (independent contractor—consultant). SW, TG, SS, MF, JF, RH, PW, NB-H and JK have no conflicts.
